These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3296211)

  • 1. The use of interferon in the treatment of multiple myeloma.
    Costanzi JJ; Pollard RB
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):24-8. PubMed ID: 3296211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferons in the treatment of multiple myeloma.
    Cooper MR; Welander CE
    Cancer; 1987 Feb; 59(3 Suppl):594-600. PubMed ID: 3802025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferons in the treatment of multiple myeloma.
    Cooper MR
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):13-20. PubMed ID: 3764441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.
    Cooper MR; Fefer A; Thompson J; Case DC; Kempf R; Sacher R; Neefe J; Bickers J; Scarffe JH; Spiegel RJ
    Invest New Drugs; 1987; 5 Suppl():S41-6. PubMed ID: 3597002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study.
    Salmon SE; Crowley JJ; Grogan TM; Finley P; Pugh RP; Barlogie B
    J Clin Oncol; 1994 Nov; 12(11):2405-14. PubMed ID: 7964957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interferon in the treatment of multiple myeloma].
    Kuzmits R; Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Flener R; Scheithauer W
    Acta Med Austriaca; 1985; 12(5):135-8. PubMed ID: 3914174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B study.
    Cooper MR; Dear K; McIntyre OR; Ozer H; Ellerton J; Canellos G; Bernhardt B; Duggan D; Faragher D; Schiffer C
    J Clin Oncol; 1993 Jan; 11(1):155-60. PubMed ID: 8418228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma.
    Costanzi JJ; Cooper MR; Scarffe JH; Ozer H; Grubbs SS; Ferraresi RW; Pollard RB; Spiegel RJ
    J Clin Oncol; 1985 May; 3(5):654-9. PubMed ID: 3998782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alfa-2b with VMCP compared to VMCP alone for induction and interferon alfa-2b compared to controls for remission maintenance in multiple myeloma: interim results.
    Ludwig H; Cohen AM; Huber H; Nachbaur D; Jungi WF; Senn H; Günczler P; Schüller J; Eckhardt S; Seewann HL
    Eur J Cancer; 1991; 27 Suppl 4():S40-5. PubMed ID: 1799476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon therapy during the plateau phase of multiple myeloma: an update of a Swedish multicenter study.
    Westin J
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):37-40. PubMed ID: 1948128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.
    Cooper MR; Fefer A; Thompson J; Case DC; Kempf R; Sacher R; Neefe J; Bickers J; Scarffe JH; Spiegel R
    Cancer Treat Rep; 1986 Apr; 70(4):473-6. PubMed ID: 3698041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction treatment with alpha-interferon in multiple myeloma: an interim report from MGCS.
    Mellstedt H; Osterborg A; Björkholm M; Björeman M; Brenning G; Gahrton G; Grimfors G; Gyllenhammar H; Hast R; Johansson B
    Eur J Haematol Suppl; 1989; 51():124-8. PubMed ID: 2697585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group.
    Browman GP; Bergsagel D; Sicheri D; O'Reilly S; Wilson KS; Rubin S; Belch A; Shustik C; Barr R; Walker I
    J Clin Oncol; 1995 Sep; 13(9):2354-60. PubMed ID: 7666094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the clinical studies of alpha-interferon in the management of multiple myeloma.
    Cooper MR
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):18-29. PubMed ID: 1948125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experience.
    Cohen AM; Meytes D; Many A; Brenner B; Aghai E; Shaklai M; Kaufman S; Shtalrid M; Attias D; Manor Y
    Isr J Med Sci; 1995 Oct; 31(10):604-10. PubMed ID: 7591683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melphalan and prednisone (MP) versus vincristine, BCNU, adriamycin, melphalan and dexamethasone (VBAM Dex) induction chemotherapy and interferon maintenance treatment in multiple myeloma. Current results of a multicenter trial. The German Myeloma Treatment Group.
    Peest D; Deicher H; Coldewey R; Leo R; Bartl R; Bartels H; Braun HJ; von Broen IM; Fischer JT; Gramatzki M
    Onkologie; 1990 Dec; 13(6):458-60. PubMed ID: 2092283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-2a-interferon/melphalan/prednisone versus melphalan/prednisone in previously untreated patients with multiple myeloma.
    Montuoro A; De Rosa L; De Blasio A; Pacilli L; Petti N; De Laurenzi A
    Br J Haematol; 1990 Nov; 76(3):365-8. PubMed ID: 2261347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial.
    Ludwig H; Cortelezzi A; Scheithauer W; Van Camp BG; Kuzmits R; Fillet G; Peetermans M; Polli E; Flener R
    Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1111-6. PubMed ID: 3536528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alfa-2b versus no maintenance therapy during the plateau phase in multiple myeloma: a randomized study. Cooperative Study Group.
    Westin J; Rödjer S; Turesson I; Cortelezzi A; Hjorth M; Zador G
    Br J Haematol; 1995 Mar; 89(3):561-8. PubMed ID: 7734355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon therapy during the plateau phase of multiple myeloma: an update of the Swedish study.
    Westin J; Cortelezzi A; Hjorth M; Rödjer S; Turesson I; Zador G
    Eur J Cancer; 1991; 27 Suppl 4():S45-8. PubMed ID: 1799477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.